(Q50569687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

B-cell depletion in the treatment of mixed cryoglobulinemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Pietro Gatti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gianfranco Lauletta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

Loredana Sansonno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Domenico Sansonno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michele Montrone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Laura Troiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

39 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

S116-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Hepatitis C virus infection and mixed cryoglobulinemia: a striking association.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

The cryoglobulins: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Cryoglobulinemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Rituximab: perspective on single agent experience, and future directions in combination trials

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

CHOP plus rituximab--balancing facts and opinion

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Rituximab for the treatment of type II mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Limited humoral immunity in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980023-5

7 January 2021

10.1016/S1590-8658(07)80023-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17936212%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference